154 related articles for article (PubMed ID: 24622707)
1. Acarbose vs metformin for new-onset type 2 diabetes.
Gallo M; Candido R; De Micheli A; Esposito K; Gentile S; Ceriello A;
Lancet Diabetes Endocrinol; 2014 Feb; 2(2):104. PubMed ID: 24622707
[No Abstract] [Full Text] [Related]
2. Acarbose vs metformin for new-onset type 2 diabetes.
Tsujimoto T; Yamamoto-Honda R
Lancet Diabetes Endocrinol; 2014 Feb; 2(2):104-5. PubMed ID: 24622706
[No Abstract] [Full Text] [Related]
3. Acarbose vs metformin for new-onset type 2 diabetes--author's reply.
Yang W
Lancet Diabetes Endocrinol; 2014 Feb; 2(2):105. PubMed ID: 24622708
[No Abstract] [Full Text] [Related]
4. Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?
Ma RC
Lancet Diabetes Endocrinol; 2014 Jan; 2(1):6-7. PubMed ID: 24622656
[No Abstract] [Full Text] [Related]
5. [Initial treatment of type 2 diabetes: metformin also for the Chinese!].
Chanson P; Cordier JF; Pariente A
Rev Prat; 2014 Apr; 64(4):470. PubMed ID: 24855777
[No Abstract] [Full Text] [Related]
6. [Thus to avoid complications of diabetes. To combine early].
MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
[No Abstract] [Full Text] [Related]
7. Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study.
Chang CH; Chang YC; Lin JW; Chen ST; Chuang LM; Lai MS
J Clin Endocrinol Metab; 2015 Mar; 100(3):1121-9. PubMed ID: 25555040
[TBL] [Abstract][Full Text] [Related]
8. Comparison of glucose lowering effect of metformin and acarbose in type 2 diabetes mellitus: a meta-analysis.
Gu S; Shi J; Tang Z; Sawhney M; Hu H; Shi L; Fonseca V; Dong H
PLoS One; 2015; 10(5):e0126704. PubMed ID: 25961824
[TBL] [Abstract][Full Text] [Related]
9. Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes.
Joshi SR; Ramachandran A; Chadha M; Chatterjee S; Rathod R; Kalra S
Expert Opin Pharmacother; 2014 Aug; 15(11):1611-20. PubMed ID: 24963542
[TBL] [Abstract][Full Text] [Related]
10. Drugs for diabetes.
Abramowicz M; Zuccotti G;
Treat Guidel Med Lett; 2005 Aug; 3(36):57-62. PubMed ID: 16012392
[No Abstract] [Full Text] [Related]
11. Managing type 2 diabetes. A look at the newer agents.
Larmore SS
JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
[No Abstract] [Full Text] [Related]
12. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
[TBL] [Abstract][Full Text] [Related]
13. Acarbose for the prevention of diabetes.
Weiss D
Cleve Clin J Med; 2003 Dec; 70(12):1088; author reply 1088. PubMed ID: 14686689
[No Abstract] [Full Text] [Related]
14. Acarbose for the prevention of diabetes.
Magill SB
Cleve Clin J Med; 2003 Dec; 70(12):1088; author reply 1088. PubMed ID: 14686688
[No Abstract] [Full Text] [Related]
15. Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial.
Pan Q; Xu Y; Yang N; Gao X; Liu J; Yang W; Wang G
Medicine (Baltimore); 2016 Apr; 95(14):e3247. PubMed ID: 27057866
[TBL] [Abstract][Full Text] [Related]
16. Post-prandial carbohydrate modulation via gut--Indian perspective.
Joshi SR
J Assoc Physicians India; 2010 Nov; 58():665. PubMed ID: 21510457
[No Abstract] [Full Text] [Related]
17. The Association between Antidiabetic Agents and Leukocyte Telomere Length in the Novel Classification of Type 2 Diabetes Mellitus.
Huang J; Peng X; Dong K; Tao J; Yang Y
Gerontology; 2021; 67(1):60-68. PubMed ID: 33321495
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy with biguanides].
Sakura H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
[No Abstract] [Full Text] [Related]
19. Is there a role for metformin or acarbose as a weight-loss agent in the absence of diabetes?
Siraj ES
Cleve Clin J Med; 2003 Aug; 70(8):702-4. PubMed ID: 12959396
[No Abstract] [Full Text] [Related]
20. Managing therapy and adverse effects with antihyperglycemic agents: a focus on metformin and acarbose.
Phillips BB
Pharm Pract Manag Q; 1997 Oct; 17(3):21-31. PubMed ID: 10173308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
